Engineered Protein ACT-101 Shows Potential in Mouse Model of Colitis, Study Shows
News
Researchers have found that Alpha Cancer Technologies‘ ACT-101, an engineered protein similar to the human alpha fetoprotein (hAFP), can protect mice from developing bowel inflammation. This finding resulted from a ... Read more